Drug application
VAPRISOL (CONIVAPTAN HYDROCHLORIDE)
Drugs@FDA NDA 022016 · CUMBERLAND PHARMS
Key facts
| Drug name | VAPRISOL |
|---|---|
| Active ingredients | CONIVAPTAN HYDROCHLORIDE |
| Application type | NDA |
| Application number | 022016 |
| Company | CUMBERLAND PHARMS |
| Dosage forms | INJECTABLE, INJECTION |
| Strength | 20MG |
| Marketing status | Prescription |
| Reference listed drug | No |
| Latest submission class | Type 6 - New Indication (no longer used) |
| Latest submission status date | Feb 28, 2007 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
- Yes FDA letters on file
- Yes FDA reviews on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: